What is it about?

This paper provides a comprehensive review of the state of advancement of new drugs and vaccines against respiratory syncytial virus that are in currently clinical trials.

Featured Image

Read the Original

This page is a summary of: Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials, Influenza and Other Respiratory Viruses, June 2015, Wiley,
DOI: 10.1111/irv.12313.
You can read the full text:

Read

Contributors

The following have contributed to this page